Investors Rekindle Interest in China's AI Pharma Sector, Though Tangible Results Are Yet to Come
Investor interest in China's AI -driven pharmaceutical sector is resurging, though the industry has yet to deliver clear, transformative outcomes, ...
Read the original at FirstWord Pharma ↗
- Topics
- China & GeopoliticsMarkets & InvestmentHealthcare
- Mentions
- China
- Tracked via
- “china ai”